Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Pan-cancer pharmacogenetics: Targeted sequencing panels or exome sequencing?
Laurentijn Tilleman graduated from the Faculty of Bioscience Engineering at Ghent University in 2016. He is now working on his PhD at Ghent University in the core facility for next generation sequencing (NXTGNT). His primary focus is on sequencing analysis in the field of pharmacogenomics.
In one of his recent publications, Laurentijn provides insight into some of the advantages of using IDT’s xGen™ Exome Hyb Panel for pharmacogenetics research studies. Click on the featured content below to learn more about his work and its findings!